Value of triglyceride glucose-body mass index in predicting nonalcoholic fatty liver disease in individuals with type 2 diabetes mellitus

BackgroundThere is limited data on the association between TyG-BMI and NAFLD in patients with Type 2 Diabetes Mellitus (T2DM). The magnitude of risk prediction and predictive efficacy of TyG-BMI for T2DM with NAFLD remains unclear.ObjectiveTo examine the association of TyG-BMI with NAFLD in T2DM pat...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiaoyi Qian, Wenwen Wu, Boyang Chen, Simin Zhang, Chunmei Xiao, Long Chen, Jun Chen, Lingli Ke, Meian He, Xiulou Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2024.1425024/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832594050882994176
author Xiaoyi Qian
Wenwen Wu
Boyang Chen
Simin Zhang
Chunmei Xiao
Long Chen
Jun Chen
Jun Chen
Lingli Ke
Meian He
Xiulou Li
Xiulou Li
Xiulou Li
author_facet Xiaoyi Qian
Wenwen Wu
Boyang Chen
Simin Zhang
Chunmei Xiao
Long Chen
Jun Chen
Jun Chen
Lingli Ke
Meian He
Xiulou Li
Xiulou Li
Xiulou Li
author_sort Xiaoyi Qian
collection DOAJ
description BackgroundThere is limited data on the association between TyG-BMI and NAFLD in patients with Type 2 Diabetes Mellitus (T2DM). The magnitude of risk prediction and predictive efficacy of TyG-BMI for T2DM with NAFLD remains unclear.ObjectiveTo examine the association of TyG-BMI with NAFLD in T2DM patients and assess the effectiveness of screening using the TyG-BMI index.MethodsWe conducted a retrospective analysis of clinical data from 602 T2DM patients at an enterprise health lodge from September 2021 to November 2022. Patients were categorized into two groups: T2DM alone (n=250) and T2DM with NAFLD (n=352). The Mann-Whitney U test was used for comparing non-normally distributed continuous data between groups, while the Chi-square test was used for categorical data. Logistic regression analysis was performed to evaluate the effect of BMI, TyG index, and TyG-BMI index on NAFLD. The ROC curve was used to assess the predictive efficacy of the TyG-BMI index for NAFLD in T2DM patients.ResultsBMI predicted the development of NAFLD in T2DM patients with an area under the receiver operating characteristic (ROC) curve of 0.792 (95% CI 0.757-0.828), and the optimal cutoff value was 25.22, with 72.2% sensitivity and 71.6% specificity; The area under the receiver operating characteristic (ROC) curve of the TyG index to predict the development of NAFLD in patients with T2DM was 0.755 (95% CI 0.716-0.794), and the optimal cutoff value was 8. 945, with a sensitivity of 80.1% and a specificity of 59.2%; The area under the receiver operating characteristic (ROC) curve of TyG-BMI index to predict the development of NAFLD in T2DM patients was 0.852, (95% CI 0.822-0.882), and the optimal cutoff value was 227.385, with a sensitivity and specificity of 80.1% and 59.2%, respectively.ConclusionsThe TyG-BMI index is a significant predictor of comorbid NAFLD in T2DM patients and provides better screening performance than BMI alone. The TyG-BMI index shows promise as an early screening tool for NAFLD in T2DM patients.
format Article
id doaj-art-14de380124704b01a6cbdceb68976162
institution Kabale University
issn 1664-2392
language English
publishDate 2025-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Endocrinology
spelling doaj-art-14de380124704b01a6cbdceb689761622025-01-20T05:23:53ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922025-01-011510.3389/fendo.2024.14250241425024Value of triglyceride glucose-body mass index in predicting nonalcoholic fatty liver disease in individuals with type 2 diabetes mellitusXiaoyi Qian0Wenwen Wu1Boyang Chen2Simin Zhang3Chunmei Xiao4Long Chen5Jun Chen6Jun Chen7Lingli Ke8Meian He9Xiulou Li10Xiulou Li11Xiulou Li12Department of Public Health, Hubei University of Medicine, Shiyan, Hubei, ChinaDepartment of Public Health, Hubei University of Medicine, Shiyan, Hubei, ChinaDepartment of Nutrition and Food Hygiene, Hubei Key Laboratory of Food Nutrition and Safety, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, ChinaDepartment of Public Health, Hubei University of Medicine, Shiyan, Hubei, ChinaDepartment of Health Examination Center, Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Shiyan, Hubei, ChinaDepartment of Health Examination Center, Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Shiyan, Hubei, ChinaDepartment of Public Health, Hubei University of Medicine, Shiyan, Hubei, ChinaDepartment of Health Examination Center, Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Shiyan, Hubei, ChinaDepartment of Health Examination Center, Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Shiyan, Hubei, ChinaDepartment of Occupational and Environmental Health, Ministry of Education and State Key Laboratory of Environmental Health (Incubating), School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaDepartment of Public Health, Hubei University of Medicine, Shiyan, Hubei, ChinaDepartment of Nutrition and Food Hygiene, Hubei Key Laboratory of Food Nutrition and Safety, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, ChinaDepartment of Health Examination Center, Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Shiyan, Hubei, ChinaBackgroundThere is limited data on the association between TyG-BMI and NAFLD in patients with Type 2 Diabetes Mellitus (T2DM). The magnitude of risk prediction and predictive efficacy of TyG-BMI for T2DM with NAFLD remains unclear.ObjectiveTo examine the association of TyG-BMI with NAFLD in T2DM patients and assess the effectiveness of screening using the TyG-BMI index.MethodsWe conducted a retrospective analysis of clinical data from 602 T2DM patients at an enterprise health lodge from September 2021 to November 2022. Patients were categorized into two groups: T2DM alone (n=250) and T2DM with NAFLD (n=352). The Mann-Whitney U test was used for comparing non-normally distributed continuous data between groups, while the Chi-square test was used for categorical data. Logistic regression analysis was performed to evaluate the effect of BMI, TyG index, and TyG-BMI index on NAFLD. The ROC curve was used to assess the predictive efficacy of the TyG-BMI index for NAFLD in T2DM patients.ResultsBMI predicted the development of NAFLD in T2DM patients with an area under the receiver operating characteristic (ROC) curve of 0.792 (95% CI 0.757-0.828), and the optimal cutoff value was 25.22, with 72.2% sensitivity and 71.6% specificity; The area under the receiver operating characteristic (ROC) curve of the TyG index to predict the development of NAFLD in patients with T2DM was 0.755 (95% CI 0.716-0.794), and the optimal cutoff value was 8. 945, with a sensitivity of 80.1% and a specificity of 59.2%; The area under the receiver operating characteristic (ROC) curve of TyG-BMI index to predict the development of NAFLD in T2DM patients was 0.852, (95% CI 0.822-0.882), and the optimal cutoff value was 227.385, with a sensitivity and specificity of 80.1% and 59.2%, respectively.ConclusionsThe TyG-BMI index is a significant predictor of comorbid NAFLD in T2DM patients and provides better screening performance than BMI alone. The TyG-BMI index shows promise as an early screening tool for NAFLD in T2DM patients.https://www.frontiersin.org/articles/10.3389/fendo.2024.1425024/fulltype 2 diabetes mellitusbody mass indextriglyceride glucose body mass indexnonalcoholic fatty liver diseasereceiver operating characteristic curve
spellingShingle Xiaoyi Qian
Wenwen Wu
Boyang Chen
Simin Zhang
Chunmei Xiao
Long Chen
Jun Chen
Jun Chen
Lingli Ke
Meian He
Xiulou Li
Xiulou Li
Xiulou Li
Value of triglyceride glucose-body mass index in predicting nonalcoholic fatty liver disease in individuals with type 2 diabetes mellitus
Frontiers in Endocrinology
type 2 diabetes mellitus
body mass index
triglyceride glucose body mass index
nonalcoholic fatty liver disease
receiver operating characteristic curve
title Value of triglyceride glucose-body mass index in predicting nonalcoholic fatty liver disease in individuals with type 2 diabetes mellitus
title_full Value of triglyceride glucose-body mass index in predicting nonalcoholic fatty liver disease in individuals with type 2 diabetes mellitus
title_fullStr Value of triglyceride glucose-body mass index in predicting nonalcoholic fatty liver disease in individuals with type 2 diabetes mellitus
title_full_unstemmed Value of triglyceride glucose-body mass index in predicting nonalcoholic fatty liver disease in individuals with type 2 diabetes mellitus
title_short Value of triglyceride glucose-body mass index in predicting nonalcoholic fatty liver disease in individuals with type 2 diabetes mellitus
title_sort value of triglyceride glucose body mass index in predicting nonalcoholic fatty liver disease in individuals with type 2 diabetes mellitus
topic type 2 diabetes mellitus
body mass index
triglyceride glucose body mass index
nonalcoholic fatty liver disease
receiver operating characteristic curve
url https://www.frontiersin.org/articles/10.3389/fendo.2024.1425024/full
work_keys_str_mv AT xiaoyiqian valueoftriglycerideglucosebodymassindexinpredictingnonalcoholicfattyliverdiseaseinindividualswithtype2diabetesmellitus
AT wenwenwu valueoftriglycerideglucosebodymassindexinpredictingnonalcoholicfattyliverdiseaseinindividualswithtype2diabetesmellitus
AT boyangchen valueoftriglycerideglucosebodymassindexinpredictingnonalcoholicfattyliverdiseaseinindividualswithtype2diabetesmellitus
AT siminzhang valueoftriglycerideglucosebodymassindexinpredictingnonalcoholicfattyliverdiseaseinindividualswithtype2diabetesmellitus
AT chunmeixiao valueoftriglycerideglucosebodymassindexinpredictingnonalcoholicfattyliverdiseaseinindividualswithtype2diabetesmellitus
AT longchen valueoftriglycerideglucosebodymassindexinpredictingnonalcoholicfattyliverdiseaseinindividualswithtype2diabetesmellitus
AT junchen valueoftriglycerideglucosebodymassindexinpredictingnonalcoholicfattyliverdiseaseinindividualswithtype2diabetesmellitus
AT junchen valueoftriglycerideglucosebodymassindexinpredictingnonalcoholicfattyliverdiseaseinindividualswithtype2diabetesmellitus
AT linglike valueoftriglycerideglucosebodymassindexinpredictingnonalcoholicfattyliverdiseaseinindividualswithtype2diabetesmellitus
AT meianhe valueoftriglycerideglucosebodymassindexinpredictingnonalcoholicfattyliverdiseaseinindividualswithtype2diabetesmellitus
AT xiulouli valueoftriglycerideglucosebodymassindexinpredictingnonalcoholicfattyliverdiseaseinindividualswithtype2diabetesmellitus
AT xiulouli valueoftriglycerideglucosebodymassindexinpredictingnonalcoholicfattyliverdiseaseinindividualswithtype2diabetesmellitus
AT xiulouli valueoftriglycerideglucosebodymassindexinpredictingnonalcoholicfattyliverdiseaseinindividualswithtype2diabetesmellitus